The GLP is committed to full transparency. Download and review our 2019 Annual Report

Congress demands EPA explain why it’s delaying ‘final’ report finding glyphosate safe

| | June 1, 2016
c ca cff b
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Two congressional committees — the House Committee on Science, Space and Technology and the House Agriculture Committee — have asked EPA Administrator Gina McCarthy to explain why her agency took the [glyphosate] assessment offline and is continuing to delay its release. On April 29, the EPA posted a report concluding that glyphosate (the active ingredient in Roundup herbicide and other products) is “not likely to be carcinogenic.” . . . . But the EPA took it down on May 2, claiming the documents were “inadvertently” posted and only a preliminary report. “EPA has not completed our cancer review. We will look at the work of other governments. . . . our assessment will be peer reviewed and completed by end of 2016,” said an EPA spokeswoman.

Related article:  What are the Challenges Facing Modern Farming Around the World?

. . . .

[House Science Committee chairman Lamar Smith] . . . senses that EPA foot-dragging might be based more on politics than on science: “That the EPA would remove a report. . .appears to be yet another example of this agency’s attempt to allow politics rather than science [to] drive its decision making. Sound, transparent science should always be the basis for EPA’s decisions.”

Read full, original post: The EPA vs. Science

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend